000 01163 a2200385 4500
005 20250512035438.0
264 0 _c19880902
008 198809s 0 0 eng d
022 _a0001-5792
024 7 _a10.1159/000205602
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeoni, F
245 0 0 _a13-cis-Retinoic acid treatment in patients with myelodysplastic syndrome.
_h[electronic resource]
260 _bActa haematologica
_c1988
300 _a8-12 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aBlood Cell Count
_xdrug effects
650 0 4 _aBlood Platelets
650 0 4 _aFemale
650 0 4 _aGranulocytes
650 0 4 _aHemoglobins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIsotretinoin
650 0 4 _aMale
650 0 4 _aMyelodysplastic Syndromes
_xblood
650 0 4 _aReticulocytes
650 0 4 _aTretinoin
_xadverse effects
700 1 _aCiolli, S
700 1 _aLongo, G
700 1 _aMessori, A
700 1 _aFerrini, P R
773 0 _tActa haematologica
_gvol. 80
_gno. 1
_gp. 8-12
856 4 0 _uhttps://doi.org/10.1159/000205602
_zAvailable from publisher's website
999 _c3141493
_d3141493